Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00791245 · ClinicalTrials.gov registry record

Post Market Study of DeNovo NT, Natural Tissue Graft

A clinical trial of Cartilage Repair, sponsored by Zimmer Orthobiologics.

Completed
Registry status
25
Enrollment target
3
Study locations

NCT00791245 is a study of Cartilage Repair that has completed, run by Zimmer Orthobiologics. The registered enrollment target is 25 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00791245, a study of Cartilage Repair, has completed, sponsored by Zimmer Orthobiologics.

COMPLETED
Registry status
25 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human knee joint.

Conditions Studied

Interventions

  • BIOLOGICAL Particulated Juvenile Cartilage Allograft

Study Locations (3)

Illinois

  • Midwest Orthopaedics at Rush - Chicago

Indiana

  • OrthoIndy - Indianapolis

New Mexico

  • New Mexico Orthopaedic Association, PC - Albuquerque

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2006-01
Est. Completion 2012-08

Sponsor

Zimmer Orthobiologics

2 total trials

What the Registry Record Tells You About NCT00791245

The ClinicalTrials.gov registry entry for NCT00791245 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Orthobiologics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cartilage Repair appearing as the primary indexed condition, and to 1 intervention - of which Particulated Juvenile Cartilage Allograft is the first listed.

NCT00791245 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Indiana, New Mexico.

Frequently Asked Questions

What is clinical trial NCT00791245 about?

NCT00791245 is a clinical study titled "Post Market Study of DeNovo NT, Natural Tissue Graft". The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human knee joint.

What is the current status of trial NCT00791245?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2006-01. Estimated completion is 2012-08.

What conditions does trial NCT00791245 study?

This clinical trial studies the following conditions: Cartilage Repair.

What interventions are being tested in trial NCT00791245?

The interventions under investigation include: Particulated Juvenile Cartilage Allograft (BIOLOGICAL).

Who is sponsoring clinical trial NCT00791245?

This trial is sponsored by Zimmer Orthobiologics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00791245 being conducted?

This trial has 3 study locations across Illinois, Indiana, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.